Avid Bioservices Inc (CDMO) concluded trading on Thursday at a closing price of $12.24, with 35.02 million shares of worth about $428.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 50.37% during that period and on November 07, 2024 the price saw a gain of about 11.48%. Currently the company’s common shares owned by public are about 63.57M shares, out of which, 62.87M shares are available for trading.
Stock saw a price change of 22.89% in past 5 days and over the past one month there was a price change of 18.15%. Year-to-date (YTD), CDMO shares are showing a performance of 88.31% which increased to 108.52% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.07 but also hit the highest price of $12.48 during that period. The average intraday trading volume for Avid Bioservices Inc shares is 740.51K. The stock is currently trading 18.25% above its 20-day simple moving average (SMA20), while that difference is up 16.14% for SMA50 and it goes to 41.20% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Avid Bioservices Inc (NASDAQ: CDMO) currently have 63.57M outstanding shares and institutions hold larger chunk of about 106.82% of that.
The stock has a current market capitalization of $780.85M and its 3Y-monthly beta is at 1.41. It has posted earnings per share of -$2.27 in the same period. It has Quick Ratio of 1.05 while making debt-to-equity ratio of 3.54. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CDMO, volatility over the week remained 3.82% while standing at 3.73% over the month.
Stock’s fiscal year EPS is expected to rise by 86.77% while it is estimated to increase by 76.27% in next year. EPS is likely to grow at an annualized rate of 15.00% for next 5-years, compared to annual growth of -66.86% made by the stock over the past 5-years.
Coverage by KeyBanc Capital Markets stated Avid Bioservices Inc (CDMO) stock as an Overweight in their note to investors on March 14, 2023, suggesting a price target of $20 for the stock. On December 08, 2021, KeyBanc Capital Markets Downgrade their recommendations, while on March 17, 2021, RBC Capital Mkts Initiated their ratings for the stock with a price target of $21. Stock get an Overweight rating from KeyBanc Capital Markets on November 10, 2020.
